Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in Diabetes Complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.

Article  PubMed  Google Scholar 

Inernational. Diabetes federation DIABETES ATLAS, Tenth edition 2021.

Association AD. 2. Classification and diagnosis of Diabetes: standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement1):14–S31.

Article  Google Scholar 

Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, et al. Diabetic Peripheral Neuropathy: Epidemiology, diagnosis, and Pharmacotherapy. Clin Ther. 2018;40(6):828–49.

Article  PubMed  Google Scholar 

Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep. 2014;14(8):473.

Article  PubMed  PubMed Central  Google Scholar 

Young M, Boulton A, MacLeod A, Williams D, Sonksen P. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–4.

Article  CAS  PubMed  Google Scholar 

Walter-Höliner I, Barbarini DS, Lütschg J, Blassnig-Ezeh A, Zanier U, Saely CH, et al. High prevalence and incidence of diabetic peripheral neuropathy in children and adolescents with type 1 Diabetes Mellitus: results from a five-year prospective cohort study. Pediatr Neurol. 2018;80:51–60.

Article  PubMed  Google Scholar 

Boulton A, Gries F, Jervell J. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med. 1998;15(6):508–14.

Article  CAS  Google Scholar 

Federation ID. IDF Diabetes atlas ninth. Dunia: IDF; 2019.

Google Scholar 

Alleman CJ, Westerhout KY, Hensen M, Chambers C, Stoker M, Long S, et al. Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature. Diabetes Res Clin Pract. 2015;109(2):215–25.

Article  Google Scholar 

Pfannkuche A, Alhajjar A, Ming A, Walter I, Piehler C, Mertens PR. Prevalence and risk factors of diabetic peripheral neuropathy in a diabetics cohort: Register initiative Diabetes and nerves. Endocr Metabolic Sci. 2020;1(1–2):100053.

Article  Google Scholar 

Sobhani S, Asayesh H, Sharifi F, Djalalinia S, Baradaran HR, Arzaghi SM, et al. Prevalence of diabetic peripheral neuropathy in Iran: a systematic review and meta-analysis. J Diabetes Metabolic Disorders. 2014;13(1):1–7.

Article  Google Scholar 

Shiferaw WS, Akalu TY, Work Y, Aynalem YA. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis. BMC Endocr Disorders. 2020;20:1–9.

Article  Google Scholar 

Gudina EK, Amade ST, Tesfamichael FA, Ram R. Assessment of quality of care given to diabetic patients at Jimma University Specialized Hospital Diabetes follow-up clinic, Jimma, Ethiopia. BMC Endocr Disorders. 2011;11(1):1–9.

Article  Google Scholar 

Worku D, Hamza L, Woldemichael K. Patterns of diabetic Complications at jimma university specialized hospital, southwest Ethiopia. Ethiop J Health Sci. 2010;20(1).

Abdissa D, Hamba N, Kene K, Bedane DA, Etana G, Muleta D et al. Prevalence and Determinants of peripheral neuropathy among type 2 adult diabetes patients attending jimma university medical center, southwest ethiopia, 2019, an institutional-based cross-sectional study. Journal of diabetes research. 2020;2020.

Juster-Switlyk K, Smith AG. Updates in diabetic peripheral neuropathy. F1000Research. 2016;5.

Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.

Article  PubMed  Google Scholar 

Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 Diabetes Mellitus in deprived areas. J Epidemiol Community Health. 2000;54(3):173–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Degu H, Wondimagegnehu A, Yifru YM, Belachew A. Is health related quality of life influenced by diabetic neuropathic pain among type II Diabetes Mellitus patients in Ethiopia? PLoS ONE. 2019;14(2):e0211449.

Article  CAS  PubMed Central  Google Scholar 

Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, et al. Risk factors for Incident Diabetic Polyneuropathy in a Cohort with screen-detected type 2 Diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care. 2018;41(5):1068–75.

Article  CAS  PubMed  Google Scholar 

Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, et al. Prevalence of and risk factors for Diabetic Peripheral Neuropathy in Youth with Type 1 and type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care. 2017;40(9):1226–32.

Article  CAS  PubMed  Google Scholar 

Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 Diabetes Mellitus in a tertiary care setting. J Diabetes Invest. 2014;5(6):714–21.

Article  Google Scholar 

Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MR, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr. 2012;4(1):1–8.

Article  Google Scholar 

Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 Diabetes Mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10:8.

Article  PubMed  PubMed Central  Google Scholar 

Gebabo TF, Zewdie TH, Shagaro SS, Haile F. Determinants of peripheral neuropathy among diabetic patients under follow-up in chronic care clinics of public hospitals at Gamo and Gofa zones, southern Ethiopia. PLoS ONE. 2021;16(2):e0246722.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Javed S, Hayat T, Menon L, Alam U, Malik RA. Diabetic peripheral neuropathy in people with type 2 Diabetes: too little too late. Diabet Med. 2020;37(4):573–9.

Article  CAS  PubMed  Google Scholar 

Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983:499–503.

Kebede SA, Tusa BS, Weldesenbet AB, Tessema ZT, Ayele TA. Time to diabetic neuropathy and its predictors among newly diagnosed type 2 Diabetes Mellitus patients in Northwest Ethiopia. Egypt J Neurol Psychiatry Neurosurg. 2021;57(1):1–7.

Article  Google Scholar 

Gylfadottir SS, Weeracharoenkul D, Andersen ST, Niruthisard S, Suwanwalaikorn S, Jensen TS. Painful and non-painful diabetic polyneuropathy: clinical characteristics and diagnostic issues. J Diabetes Invest. 2019;10(5):1148–57.

Article  Google Scholar 

Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema Disease severity scales. Ophthalmology. 2003;110(9):1677–82.

WHO. Regional Office for the Western Pacific. (‎2017)‎. Noncommunicable disease education manual for primary health care professionals and patients. Manila: WHO Regional Office for the Western Pacific. 2017 [Available from: https://apps.who.int/iris/handle/10665/254746.

Kisozi T, Mutebi E, Kisekka M, Lhatoo S, Sajatovic M, Kaddumukasa M, et al. Prevalence, severity and factors associated with peripheral neuropathy among newly diagnosed diabetic patients attending Mulago hospital: a cross-sectional study. Afr Health Sci. 2017;17(2):463–73.

Article  PubMed  Google Scholar 

Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 Diabetes Mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10(1):1–10.

Google Scholar 

Aleidan FAS, Ahmad BA, Alotaibi FA, Aleesa DH, Alhefdhi NA, Badri M, et al. Prevalence and risk factors for Diabetic Peripheral Neuropathy among Saudi Hospitalized Diabetic patients: a nested case-control study. Int J Gen Med. 2020;13:881–9.

Article  PubMed  PubMed Central  Google Scholar 

Yuan D, Hussain T, Tan B, Liu Y, Ji P, Yin Y. The evaluation of antioxidant and anti-inflammatory effects of Eucommia ulmoides flavones using diquat-challenged piglet models. Oxidative Medicine and Cellular Longevity. 2017;2017.

Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff M, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr. 2012;4(1):1–8.

Article  Google Scholar 

Yokoyama H, Tsuji T, Hayashi S, Kabata D, Shintani A. Factors associated with diabetic polyneuropathy-related sensory symptoms and signs in patients with polyneuropathy: a cross-sectional Japanese study (JDDM 52) using a non-linear model. J Diabetes Investig. 2020;11(2):450–7.

Article  PubMed  Google Scholar 

Group DR. Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes. 1988;37(4):476–81.

Article  Google Scholar 

D’Souza M, Kulkarni V, Unnikrishnan Bhaskaran HA, Naimish H, Prakash A, Tabreez S et al. Diabetic peripheral neuropathy and its determinants among patients attending a tertiary health care centre in Mangalore, India. J Public Health Res. 2015;4(2).

Shrestha H, Katwal P. Prevalence and risk factors of Diabetic Peripheral Neuropathy in T2DM patient presenting to Commnity Hospital in Nepal. Kathmandu Univ Med J. 2017;58(2):146–9.

Google Scholar 

Rosenson R, Fioretto P, Dodson P. Does microvascular Disease predict macrovascular events in type 2. Diabetes? Atherosclerosis. 2011;218(1):13–8.

Article  CAS  PubMed  Google Scholar 

Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, et al. Peripheral neuropathy in type 2 Diabetes Mellitus in Isfahan, Iran: prevalence and risk factors. Acta Neurol Scand. 2006;114(6):384–91.

Article  CAS  Google Scholar 

Pai Y-w, Lin C-H, Lee I-T, Chang M-H. Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(2):111-6.

Dinh Le T, Phi Thi Nguyen N, Thanh Thi Tran H, Luong Cong T, Ho Thi Nguyen L, Do Nhu B, et al. Diabetic Peripheral Neuropathy Associated with Cardiovascular Risk factors and Glucagon-Like Peptide-1 concentrations among newly diagnosed patients with type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2022;15:35–44.

Article  CAS  PubMed  Google Scholar 

Hu Y, Liu F, Shen J, Zeng H, Li L, Zhao J, et al. Association between serum cystatin C and diabetic peripheral neuropathy: a cross-sectional study of a Chinese type 2 diabetic population. Eur J Endocrinol. 2014;171(5):641–8.

Article  CAS  PubMed  Google Scholar 

Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA. 2015;314(20):2172–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang C-S, Pai Y-W, Lin C-H, Lee I-T, Chang M-H. Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study. Sci Rep. 2022;12(1):1–9.

Google Scholar